Skip to main content
Premium Trial:

Request an Annual Quote

Asper Finds Distributor in Italy

NEW YORK, Jan. 13-The Estonian genotyping firm Asper has made a distribution deal with the Italian company Resnova, Asper said today.

 

Resnova, which distributes molecular biology products to pharmaceutical companies, biotech firms, clinical labs, and research institutions, will be the exclusive distributor of Asper's products and services in Italy.

 

Asper provides medium throughput SNP genotyping services, instrumentation, software and reagents.

 

For further information, see the company statement

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.